Wikipedia

Cutar Covid-19 A Cikin Ciki

Tasiri

Cutar Covid-19 A Cikin Ciki
Description (en) Fassara
Iri Koronavirus 2019
infection in pregnancy (en) Fassara
Identifier (en) Fassara
Allura kariya daga Korona

Hasashen da aka danganta da irin wannan cututtuka irin su SAS da MERS sun nuna cewa mata masu juna biyu suna cikin haɗarin kamuwa da cuta mai tsanani[1][2] amma bincike daga bincike har zuwa yau ya nuna cewa halayen asibiti na COVID-19 ciwon huhu a cikin mata masu juna biyu sun yi kama da wadanda an ruwaito daga manya marasa ciki.[3][4]

Yanda korona ke wa Dan adam

Babu wani bayanan da ke nuna haɗarin zubar da ciki na asarar ciki saboda COVID-19 kuma binciken da aka yi tare da SARS da MERS ba sa nuna alaƙa tsakanin kamuwa da kuma cuta da zubar da ciki ko asara na biyu na uku.[5]

Ba a sani ba tukuna ko yanayin da ke tasowa yayin daukar ciki ciki har da ciwon sukari, gazawar zuciya, hypercoagulability ko hauhawar jini na iya wakiltar ƙarin abubuwan haɗari ga mata masu juna biyu kamar yadda suke yi ga mata marasa ciki.[3]

Daga ƙayyadaddun bayanai da ake da su, watsawa a tsaye a cikin uku na uku mai yiwuwa ba ya faruwa, ko kuma kawai yana faruwa da wuya. Har yanzu babu bayanai kan farkon daukar ciki. [3]

Bincike game da COVID-19 a cikin ciki

gyara sashe

Shaidu kaɗan sun wanzu don ba da damar kowane tabbataccen sakamako game da yanayin kamuwa da COVID-19 a cikin ciki.[6]

Tasiri akan mata masu juna biyu

gyara sashe

A cikin Mayu 2020, Kwalejin Royal na Ma'aikatan Lafiya da Gynecologists (RCOG) da Royal College of Midwives (RCM) sun ba da rahoton sakamakon binciken Tsarin Kula da Mace na Burtaniya (UKOSS) na mata masu juna biyu 427 da jariransu.[7] Wannan binciken ya nuna cewa mata masu juna biyu 4.9 a cikin 1000 an shigar da su asibiti tare da COVID-19 kuma 1 cikin 10 na waɗannan suna buƙatar kulawa mai zurfi.[8]

Sakamakon binciken wannan binciken ya goyi bayan shawarwarin da suka gabata cewa mata masu juna biyu ba su da haɗarin rashin lafiya mai tsanani fiye da mata marasa ciki. Hakanan ana amfani da irin waɗannan abubuwan haɗari: matan da ke cikin binciken sun fi dacewa a kwantar da su a asibiti idan sun tsufa, kiba ko kiba, ko kuma suna da yanayin da suka gabata kamar ciwon sukari ko hawan jini.[7] Mata biyar ne suka mutu amma har yanzu ba a bayyana ko kwayar cutar ta yi sanadiyar mutuwar ba.[7] Tunda yawancin matan da suka yi rashin lafiya sun kasance a cikin uku na uku na ciki, RCOG da RCM sun jaddada mahimmancin nisantar da jama'a ga wannan rukunin.[7] Binciken ya kuma gano cewa kashi 55% na mata masu juna biyu da aka kwantar a asibiti tare da COVID-19 sun fito ne daga bakar fata ko kuma wasu tsirarun kabilu (BAME), wanda ya zarce adadin matan BAME a cikin jama'ar Burtaniya. Da take magana ga RCOG, Dr Christine Ekechi ta ce yana da matukar damuwa cewa sama da rabin wadanda aka kwantar a asibiti sun fito ne daga asalin BAME, cewa an riga an sami "rauni mai dorewa" ga wannan rukunin, kuma RCOG tana sabunta jagora. don rage ƙofa don bita, yarda da la'akari da haɓaka kulawa ga mata masu ciki na asalin BAME.[7] Haɗin gwiwar Bincike da Bincike na Burtaniya a cikin Likitan Mata da Gynecology sun gudanar da babban kimantawa na ayyukan kula da lafiyar mata a Burtaniya dangane da yanayin bala'in cutar, ana buƙatar ƙarin aiki a cikin dogon lokaci don samar da sabis na kula da mata masu juna biyu.[9][10]

Jerin shari'o'in mata 43 daga New York waɗanda suka gwada inganci don COVID-19 sun nuna irin wannan tsari ga manya waɗanda ba masu juna biyu ba: 86% suna da ƙarancin cuta, 9.3% suna da cuta mai tsanani kuma 4.7% sun kamu da cuta mai mahimmanci.[11] Wani bincike ya gano lamuran COVID-19 ciwon huhu a cikin ciki sun fi sauƙi kuma suna da murmurewa.[12]

Wani bincike na mata 9 da suka kamu da cutar a cikin uku na uku na ciki daga Wuhan, China, ya nuna cewa sun nuna zazzabi (a cikin shida daga cikin marasa lafiya tara), ciwon tsoka (cikin uku), ciwon makogwaro (cikin biyu) da rashin lafiya (cikin biyu). Bacin rai tayi ta shiga biyu. Babu daya daga cikin matan da ya kamu da cutar COVID-19 mai tsanani ko kuma ta mutu. Dukkansu suna da ciki mai rai kuma ba a ga ciwon asphyxia mai tsanani ba. Samfurori na madarar nono, ruwan amniotic, jinin igiya da swab na makogwaro na jarirai an gwada su don SARS-CoV-2, kuma duk sakamakon ya kasance mara kyau.[4]

A wani binciken kan mata masu juna biyu 15, yawancin marasa lafiya sun nuna zazzabi da tari, yayin da gwaje-gwajen dakin gwaje-gwaje suka haifar da lymphocytopenia a cikin marasa lafiya 12.[12] Abubuwan da aka lissafa na waɗannan marasa lafiya sun yi daidai da rahotannin baya-bayan nan game da marasa lafiya marasa ciki, wanda ya ƙunshi ƙarancin gilashin ƙasa a matakin farko.[12][13] Hotunan da aka biyo bayan bayarwa ba su nuna ci gaban ciwon huhu ba.[12]

Rahotanni daga kafafen yada labarai sun nuna cewa sama da mata 100 da ke dauke da COVID-19 na iya haihuwa, kuma a cikin Maris 2020, ba a sami rahoton mutuwar mata masu juna biyu ba.[14] A watan Afrilun 2020, wata mata mai juna biyu mai shekaru 27 da haihuwa a cikin makonni 30 ta mutu a Iran ; Mutuwar ta na iya kasancewa COVID-19 ne ya haddasa ta.[15]

RCOG ta ba da shawarar a farkon Afrilu 2020 cewa saboda ciki yanayi ne na hypercoagulable kuma mutanen da aka kwantar da su a asibiti tare da COVID-19 suma suna da karfin jini, kamuwa da cutar COVID-19 na iya ƙara haɗarin thromboembolism mai jijiya kuma wannan haɗarin na iya haɓaka ta hanyar rage motsi. saboda ware kai.[16] Sharuɗɗan nasu don haka suna ba da shawarar cewa duk mace mai ciki da aka shigar da ita asibiti tare da kamuwa da cuta ta COVID-19 ya kamata ta sami aƙalla kwanaki 10 na heparin mai ƙarancin nauyi na prophylactic bayan an sallame ta daga asibiti.[17]

Kwanan nan, an ƙaddamar da Rijistar International ta Coronavirus Exposure in Pregnancy (IRCEP) a matsayin haɗin gwiwa tsakanin Pregistry da Harvard TH Chan Makarantar Kiwon Lafiyar Jama'a.[18]

Tasiri akan aiki

gyara sashe

Akwai ƙayyadaddun bayanai game da illolin cututtukan COVID-19 ga aiki.[3] Al-kuraishy et al. An ba da rahoton cewa COVID-19 a cikin ciki na iya ƙara haɗarin haihuwa kafin haihuwa. Ana ɗaukar haihuwa da wuri a matsayin babban sakamako na COVID-19 ciwon huhu yayin daukar ciki.[16] Binciken UKOSS ya gano cewa matsakaicin shekarun haihuwa a lokacin haihuwa shine makonni 38 kuma kashi 27% na matan da aka yi nazari sun haihu kafin haihuwa. Daga cikin wadannan, kashi 47% an yi musu maganin ne saboda hadarin da ke tattare da lafiyar uwa kuma kashi 15% na faruwa ne saboda hadarin da tayi.[5]

Tasiri kan tayin

gyara sashe

A halin yanzu babu wani bayani da zai nuna ƙarin haɗarin zubar da ciki ko asarar ciki da wuri dangane da COVID-19.[16]

Watsawa

gyara sashe

Nazarin farko ya nuna babu wata shaida don watsa COVID-19 a tsaye daga uwa zuwa yaro a ƙarshen ciki[4] amma ƙarin rahotannin kwanan nan sun nuna cewa watsa a tsaye na iya faruwa a wasu lokuta.[19][20][21]

Binciken farko ya gano wasu yara biyu da suka kamu da COVID-19 amma an yi la'akari da cewa yiwuwar watsawa ya faru a lokacin haihuwa.[22]

Hakanan ana iya lura cewa mahaifar ɗan adam tana bayyana abubuwan da ke da mahimmanci a cikin cututtukan COVID-19.[23]

Ƙarin ƙananan binciken da aka yi kwanan nan ya nuna cewa ana iya yiwuwa watsawa a tsaye. Yarinya yarinya da aka haifa ga uwa tare da COVID-19 ta haɓaka matakan IgM sa'o'i biyu bayan haihuwa, yana nuna cewa ta kamu da cutar a cikin mahaifa kuma tana tallafawa yuwuwar watsawa a tsaye a wasu lokuta.[19] Wani ɗan ƙaramin binciken da ya ƙunshi 6 ya tabbatar da cewa iyayen COVID-19 sun nuna babu alamun SARS-CoV-2 a cikin makogwaron jariransu ko maganin jini amma ƙwayoyin rigakafi sun kasance a cikin samfuran sera na jini na jarirai, gami da IgM a cikin jarirai biyu.[20] Ba a saba ba da wannan daga uwa zuwa tayin don haka ana buƙatar ƙarin bincike don sanin ko kwayar cutar ta ratsa mahaifa ko kuma mahaifar mata da ke cikin binciken sun lalace ko kuma sun lalace.[20]

An haifi saitin 'yan uku da wuri tare da COVID-19 a Babban Asibitin Ignacio Morones Prieto da ke San Luis Potosí, Mexico, a ranar 17 ga Yuni, 2020. Duk iyaye biyu sun gwada rashin lafiya kuma an ba da rahoton cewa yaran sun kwanta.[24]

Hasashe

gyara sashe

Tunda COVID-19 yana nuna kamanceceniya da SARS-CoV da MERS-CoV, da alama tasirinsu akan ciki yayi kama. A lokacin cutar ta 2002-03, an yi nazarin mata 12 da suka kamu da cutar ta SARS-CoV.[25] Hudu daga cikin bakwai sun sami zubar da ciki na farkon trimester, biyu daga cikin biyar sun sami ƙuntatawa girma tayi a cikin na biyu trimester, kuma hudu daga cikin biyar sun sami haihuwa kafin haihuwa. Mata uku sun mutu yayin da suke da juna biyu. Babu daya daga cikin jariran da ya kamu da cutar SARS-CoV.[25] Wani rahoto na lokuta goma na kamuwa da cutar MERS-CoV a cikin ciki a Saudi Arabiya ya nuna cewa gabatarwar asibiti yana canzawa, daga kamuwa da cuta mai laushi zuwa mai tsanani. Sakamakon ya yi kyau a mafi yawan lokuta, amma adadin mutuwar jarirai ya kasance kashi 27%.[26]

Wani bita ya nuna cewa COVID-19 da alama ba shi da kisa ga iyaye mata da jarirai fiye da SARS da MERS amma ana iya samun ƙarin haɗarin haihuwa kafin haihuwa bayan makonni 28 na ciki.[27]

Mata miliyan 47 a cikin kasashe masu karamin karfi da matsakaitan kasashe 114 UNFPA sun yi hasashen ba za su iya amfani da magungunan hana haihuwa na zamani ba idan matsakaita na kulle-kulle, ko rikice-rikicen da ke da alaka da COVID-19, ya ci gaba har na tsawon watanni 6 tare da manyan cikas ga ayyuka: A kowane watanni 3. Ana ci gaba da kulle-kulle, ana zaton an samu tartsatsi, har zuwa karin mata miliyan biyu ba za su iya amfani da maganin hana haihuwa na zamani ba. Idan aka ci gaba da kulle-kullen na tsawon watanni 6 kuma akwai manyan cikas na sabis saboda COVID-19, ana sa ran ƙarin ciki miliyan 7 da ba a yi niyya ba ta UNFPA. Adadin cikin da ba a yi niyya ba zai karu yayin da ake ci gaba da kulle-kullen da kuma tsawaita ayyukansu.[28]

Shawarwari

gyara sashe

Hukumar Lafiya ta Duniya da Cibiyar Yaki da Cututtuka ta Amurka ta shawarci mata masu juna biyu da su rika yin abubuwa iri daya da sauran jama'a don gujewa kamuwa da cutar, kamar su rufe tari, guje wa cudanya da marasa lafiya, tsaftace hannu da sabulu da ruwa ko kuma tsabtace muhalli.[29][2]

Magungunan rigakafin cutar covid-19

gyara sashe

CDC yanzu tana ƙarfafa mata masu juna biyu su sami rigakafin COVID-19 .

Gabaɗaya shawarwari

gyara sashe

Asusun kula da yawan jama'a na Majalisar Dinkin Duniya (UNFPA) ya ba da shawarar matakan gabaɗaya guda bakwai don duk lokacin saduwa da majinyata da ke fuskantar kulawa:[30]

  1. Tabbatar da ma'aikata da majiyyata samun dama ga wuraren wanke hannu masu tsabta kafin shigar da kayan aiki.
  2. Samun sabulu na yau da kullun a kowane wurin wanki na wurin kiwon lafiya tare da tsaftataccen kyalle ko tawul ɗin da za a iya zubarwa don busar da hannu.
  3. Idan ungozoma suna ba da kulawar marasa lafiya kai tsaye, dole ne su yawaita wanke hannayensu da sabulu da ruwa na akalla daƙiƙa 20 kowane lokaci. Wannan dole ne ya faru kafin a ga kowace sabuwar mace da kuma sake kafin gwajin jiki. Ungozoma su sake wankewa nan da nan bayan jarrabawar sannan kuma da zarar majiyyaci ya fita. Hakanan ya kamata a yi wanka bayan tsaftace saman da tari ko atishawa. Hakanan ana iya amfani da tsabtace hannu musamman idan babu ruwa mai tsafta.[30]
  4. Ka guji taɓa baki, hanci ko idanu.
  5. Yakamata a shawarci ma'aikata da marasa lafiya su yi tari a cikin nama ko gwiwar hannu su wanke hannu daga baya.
  6. Ungozoma yakamata su kiyaye nisan zamantakewa na akalla tsawon hannaye 2 yayin kowace ziyarar asibiti. Matukar ana yin wankin hannu kafin da bayan gwajin jiki mata ba tare da an yi zargin ko an tabbatar da COVID-19 ba, gwajin jiki da tuntubar majiyyaci ya kamata a ci gaba kamar yadda aka saba, idan an wanke hannu kafin da bayan.[30]
  7. Fesa saman da marasa lafiya da ma'aikata ke amfani da su tare da bleach ko wani. Tabbatar goge saman saman tare da tawul na takarda ko zane mai tsabta a tsakanin marasa lafiya da wanke hannu.[30]
  8. Ungozoma ne ke gudanar da haihuwa, kulawa da haihuwa da haihuwa kuma suna wakiltar wasu muhimman ayyukan kula da lafiya a bangaren kiwon lafiyar mata kuma suna da alaka kai tsaye da yawan mace-mace da cututtuka.[30]
  9. Yana da mahimmanci cewa ma'aikatan SRMNAH, ciki har da ungozoma, an haɗa su a cikin gaggawa da tsare-tsaren rarraba don karɓar isasshen PPE da kuma daidaitawa yadda ake amfani da PPE daidai.[30]
  10. Tunda kulawar ungozoma tana ci gaba da zama muhimmin sabis da mata dole ne su samu damar shiga yana da matukar muhimmanci ga ungozoma su sami tallafi, nasiha da kuma sanin yadda za su sake tsara ayyuka don ci gaba da ba da kulawa mai inganci (watau mutunta shawarwarin kiwon lafiyar jama'a na akalla. 2m tsakanin mata, kadan ne mai yiwuwa ungozoma masu kula da mace daya (kadan ma'aikata a dakin), tsaftar hannu).[30]
  11. Dole ne ungozoma su sami bayanan tushen shaida waɗanda za su iya kare kansu daga yin kwangilar COVID-19 yayin da suke kula da mace mai alama, ko kuma daga macen da ta kamu da cutar ta COVID-19.[30]
  12. Ungozoma suna taka muhimmiyar rawa wajen rage kyama da yaƙi da yada imanin cewa ya kamata a guji wuraren kiwon lafiya don kasancewa cikin koshin lafiya/ba kwangilar COVID-19.[30]
  13. Ana iya tsammanin sake tsarawa/ cire kudade daga sassan da ungozoma ke aiki a kai, za a danganta shi kai tsaye da haɓakar cututtuka na mata da jarirai da mace-mace da ke ingiza ƙasashe nesa da manufar SDG.[30]

Kulawar haihuwa

gyara sashe

RCOG da RCM suna ba da shawarar sosai cewa ya kamata a dauki kulawar haihuwa da na haihuwa a matsayin mahimmanci, kuma "mata masu ciki za su ci gaba da buƙatar aƙalla tallafi, shawara, kulawa da jagoranci dangane da ciki, haihuwa da haihuwa da wuri kamar da".[16]

A watan Mayun 2020, mai magana da yawun kungiyar RCOG ya ba da shawarar cewa ya kamata a yi gargadin bakar fata da sauran kananan kabilun mata cewa za su iya samun babbar hadarin kamuwa da cutar kuma a shawarce su da su nemi taimako da wuri idan sun damu.[7] Bugu da ƙari, ƙwararrun ƙwararrun kiwon lafiya ya kamata su san haɗarin haɓakar haɗari kuma suna da ƙaramin ƙofa don yin bita, yarda da haɓaka kulawa da aka ba wa matan BAME. [5]

Don rage haɗarin kamuwa da cuta, RCOG da RCM suna ba da shawarar cewa ana iya gudanar da wasu alƙawura daga nesa ta hanyar tarho ko taron bidiyo.[16] Wani bincike da aka gudanar a birnin Shanghai a tsakanin mata masu juna biyu a cikin watanni uku daban-daban na ciki ya nuna cewa akwai bukatar samun bayanai da ayyukan lafiya ta yanar gizo.[31] Matan da ke tsammanin jariri na farko sun fi son samun shawarwari da jagora akan layi fiye da waɗanda suka haifa a baya.[31]

RCOG da RCM sun ba da shawarar cewa a jinkirta alƙawura na cikin mutum da kwanaki 7 bayan fara alamun COVID-19 ko kwanaki 14 idan wani a gidan yana da alamun cutar.[16] Inda ake buƙatar alƙawura a cikin mutum, ana ba marasa lafiya masu juna biyu da alamun COVID-19 da aka tabbatar waɗanda ke buƙatar kulawar haihuwa su sanar da asibiti ko asibitin kafin su isa don a sanya maganin kamuwa da cuta.[3][16]

Binciken duniya a Asibitin Presbyterian Allen na New York-Presbyterian Allen da Cibiyar Kiwon Lafiya ta Jami'ar Columbia ta Irving sun gano cewa daga cikin marasa lafiya 215 masu juna biyu, hudu (1.9%) suna da alamun cutar kuma suna da alamun COVID-19 da 29 (13.7%) sun kasance asymptomatic amma an gwada inganci don wayar cutar.[32] Zazzabi daga baya ya tashi a cikin marasa lafiya uku masu asymptomatic. Ɗaya daga cikin majiyyaci da ya gwada rashin lafiya daga baya ya zama alamun bayyanar cututtuka kuma ya gwada inganci kwanaki uku bayan gwajin mara kyau na farko.[32] Likitocin da ke gudanar da gwajin sun ba da shawarar cewa don rage kamuwa da cuta da kuma ware PPE, saboda yawan adadin marasa lafiya da ke nuna alamun asymptomatic, ya kamata a gudanar da aikin tantance masu juna biyu a duniya.[32]

Lokacin aiki

gyara sashe

A cikin Burtaniya, ƙa'idodin hukuma sun nuna cewa ya kamata a ba wa mata izini kuma a ƙarfafa su su sami abokiyar haihuwa ɗaya mai asymptomatic tare da su yayin aikinsu da haihuwa.[16]

Babu wata shaida dangane da idan akwai zubar da kwayar cutar a cikin farji, don haka yanayin haihuwa (farji ko caesarean) yakamata a tattauna da matar da ke naƙuda kuma a yi la'akari da abubuwan da take so idan babu wasu abubuwan da suka dace.[14][16] Idan majiyyaci yana da shirin haihuwar caesarean ko shirin ƙaddamar da naƙuda, yakamata mutum ya tantance ko yana da lafiya a jinkirta aikin don rage haɗarin kamuwa da wasu.[16] Samfuran ciki, irin su mahaifa, amnion da sauransu. Ba a nuna su suna da kamuwa da cutar coronavirus na haihuwa ko kamuwa da cuta ba, kuma ba sa haifar da haɗarin kamuwa da cutar coronavirus.[33]

RCOG da RCM sun ba da shawarar cewa ya kamata a ba da shawarar epidural ga marasa lafiya da aka tabbatar ko ake zargi da COVID-19 a cikin naƙuda don a rage buƙatar maganin saƙar gabaɗaya idan ana buƙatar sa baki na gaggawa don haihuwa.[16] Hakanan suna ba da shawarar cewa matan da ake zargi ko waɗanda aka tabbatar da COVID-19 yakamata su ci gaba da sa ido kan tayin ta lantarki.[16] Ba a ba da shawarar yin amfani da wuraren tafkunan haihuwa ba ga waɗanda ake zargi ko tabbatar da lamuran COVID-19 saboda haɗarin kamuwa da cuta ta hanyar najasa.[16]

Kulawar bayan haihuwa

gyara sashe
 
Wani bayani daga Hukumar Lafiya ta Duniya kan matakan rigakafin COVID-19 da za a ɗauka yayin shayarwa

A Burtaniya, shawarwarin hukuma sun nuna cewa bai kamata a yi taka-tsantsan na raba uwa da jariri mai lafiya da wasa ba kuma a ajiye su tare a lokacin haihuwa inda ba a bukatar kulawar jarirai.[16] A cewar asusun kula da yawan jama'a na Majalisar Dinkin Duniya, ana karfafa wa mata gwiwa da su shayar da nonon uwa kamar yadda aka saba gwargwadon yadda zai yiwu tare da tuntubar masu ba da lafiya.[33]

Littattafai daga kasar Sin sun ba da shawarar raba iyaye mata masu kamuwa da jarirai na tsawon kwanaki 14.[16] A Amurka akwai kuma shawarar cewa dole ne a raba jarirai da iyaye mata na wani dan lokaci har sai an daina yin taka-tsantsan da ake yadawa, kuma inda hakan ba zai yiwu ba a ajiye jarirai tazarar mita 2 daga uwa.[3]

Bayan haka, wasu jagororin yanzu sun haɗa da cewa ya kamata a ƙarfafa iyaye mata masu COVID-19 su shayar da nono idan za su iya, amma su sa kayan kariya na sirri don yin hakan. An ba da wannan shawarar, ganin cewa kamuwa da ciwon jarirai gabaɗaya yana da sauƙi kuma galibi yana da asymptomatic, kuma amfanin shayarwa na iya wuce haɗarin watsawa.[34]

UNFPA ta ba da shawarar cewa yana da matukar muhimmanci duk mata su sami damar haihuwa lafiya, ci gaba da kula da mata masu juna biyu da haihuwa, gami da gwaje-gwajen tantancewa bisa ga ka'idoji da ka'idoji na kasa, musamman a wuraren barkewar cutar, inda samun damar yin hidima ga mata masu juna biyu, mata masu nakuda. da haihuwa, da kuma masu shayarwa mata suna da mummunar tasiri.[35]

Tasirin cutar ta COVID-19 ga mata masu juna biyu

gyara sashe

A cewar Majalisar Dinkin Duniya Women, da shagala da hankali da kuma m albarkatun daga lafiyar mata wajen haihuwa iya exacerbate masu juna biyu mace-mace da kuma wajen kisa da kuma kara kudi na matashi ciki.[36] Asusun kula da yawan jama'a na Majalisar Dinkin Duniya ya ba da shawarar cewa samun damar haihuwa lafiya, kulawar haihuwa, kulawar bayan haihuwa da gwaje-gwajen gwaje-gwaje bisa ka'idojin kasa yana da matukar muhimmanci, musamman a wuraren da cutar ta mamaye asibitoci, ta yadda lafiyar haihuwa ta yi tasiri sosai.[33]

Duba kuma

gyara sashe
  • Tasirin jinsi na cutar COVID-19
  • Tasirin cutar ta COVID-19 akan zubar da ciki a Amurka

Manazarta

gyara sashe
  1. ↑ Favre G, Pomar L, Musso D, Baud D (February 2020). "2019-nCoV epidemic: what about pregnancies?". Lancet. 395 (10224): e40. doi:10.1016/S0140-6736(20)30311-1. PMC 7133555. PMID 32035511.
  2. ↑ 2.0 2.1 "Q&A on COVID-19, pregnancy, childbirth and breastfeeding". www.who.int (in Turanci). Retrieved 6 April 2020.
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Mimouni F, Lakshminrusimha S, Pearlman SA, Raju T, Gallagher PG, Mendlovic J (May 2020). "Perinatal aspects on the covid-19 pandemic: a practical resource for perinatal-neonatal specialists". Journal of Perinatology. 40 (5): 820–826. doi:10.1038/s41372-020-0665-6. PMC 7147357. PMID 32277162.
  4. ↑ 4.0 4.1 4.2 Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. (March 2020). "Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records". Lancet. 395 (10226): 809–815. doi:10.1016/S0140-6736(20)30360-3. PMC 7159281. PMID 32151335.
  5. ↑ 5.0 5.1 5.2 "Coronavirus (COVID-19) infection and pregnancy Version 9" (PDF). Royal College of Obstetricians & Gynaecologists (in Turanci). 13 May 2020. Archived from the original (PDF) on 2020-06-05. Retrieved 2020-05-14.
  6. ↑ "Sexual and Reproductive Health and Rights, Maternal and Newborn Health & COVID-19". www.unfpa.org (in Turanci). Retrieved 5 June 2020.
  7. ↑ 7.0 7.1 7.2 7.3 7.4 7.5 "RCOG and RCM respond to UKOSS study of more than 400 pregnant women hospitalised with coronavirus". Royal College of Obstetricians & Gynaecologists (in Turanci). 11 May 2020. Archived from the original on 2021-01-30. Retrieved 2020-05-12.
  8. ↑ Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. (June 2020). "Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study". BMJ. 369: m2107. doi:10.1136/bmj.m2107. PMC 7277610. PMID 32513659.
  9. ↑ Rimmer MP, Al Wattar BH, et al. (UKARCOG Members) (August 2020). "Provision of obstetrics and gynaecology services during the COVID-19 pandemic: a survey of junior doctors in the UK National Health Service". BJOG. 127 (9): 1123–1128. doi:10.1111/1471-0528.16313. PMC 7283977. PMID 32460422.
  10. ↑ "UK Audit and Research Collaborative in Obstetrics and Gynaecology (UKARCOG)". ukarcog.org. Archived from the original on 2023-01-13. Retrieved 2021-11-17.
  11. ↑ Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. (May 2020). "Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals". American Journal of Obstetrics & Gynecology MFM. 2 (2): 100118. doi:10.1016/j.ajogmf.2020.100118. PMC 7144599. PMID 32292903.
  12. ↑ 12.0 12.1 12.2 12.3 Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, Zheng C (July 2020). "Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis". AJR. American Journal of Roentgenology. 215 (1): 127–132. doi:10.2214/AJR.20.23072. PMID 32186894. S2CID 213185956.
  13. ↑ Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A (July 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". AJR. American Journal of Roentgenology. 215 (1): 87–93. doi:10.2214/AJR.20.23034. PMID 32174129.
  14. ↑ 14.0 14.1 Liang H, Acharya G (April 2020). "Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?". Acta Obstetricia et Gynecologica Scandinavica. 99 (4): 439–442. doi:10.1111/aogs.13836. PMID 32141062. S2CID 212569131.
  15. ↑ Karami P, Naghavi M, Feyzi A, Aghamohammadi M, Novin MS, Mobaien A, et al. (April 2020). "WITHDRAWN: Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings". Travel Medicine and Infectious Disease: 101665. doi:10.1016/j.tmaid.2020.101665. PMC 7151464. PMID 32283217.
  16. ↑ 16.00 16.01 16.02 16.03 16.04 16.05 16.06 16.07 16.08 16.09 16.10 16.11 16.12 16.13 16.14 "Coronavirus (COVID-19) infection and pregnancy Version 7". Royal College of Obstetricians & Gynaecologists (in Turanci). 9 April 2020. Retrieved 2020-04-14.
  17. ↑ Coronavirus (COVID-19) Infection in Pregnancy (PDF) (Report). RCOG. 24 July 2020. p. 49. Retrieved 15 September 2020.
  18. ↑ "International Registry of Coronavirus Exposure in Pregnancy (IRCEP)". corona.pregistry.com (in Turanci). Archived from the original on 7 June 2020. Retrieved 7 June 2020.
  19. ↑ 19.0 19.1 Dong L, Tian J, He S, Zhu C, Wang J, Liu C, Yang J (May 2020). "Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn". JAMA. 323 (18): 1846–1848. doi:10.1001/jama.2020.4621. PMC 7099527. PMID 32215581.
  20. ↑ 20.0 20.1 20.2 Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, Long X (May 2020). "Antibodies in Infants Born to Mothers With COVID-19 Pneumonia". JAMA. 323 (18): 1848–1849. doi:10.1001/jama.2020.4861. PMC 7099444. PMID 32215589.
  21. ↑ Tripathi S, Gogia A, Kakar A (September 2020). "COVID-19 in pregnancy: A review". Journal of Family Medicine and Primary Care. 9 (9): 4536–4540. doi:10.4103/jfmpc.jfmpc_714_20. PMC 7652131. PMID 33209759.
  22. ↑ Qiao J (March 2020). "What are the risks of COVID-19 infection in pregnant women?". Lancet. 395 (10226): 760–762. doi:10.1016/S0140-6736(20)30365-2. PMC 7158939. PMID 32151334.
  23. ↑ Ashary N, Bhide A, Chakraborty P, Colaco S, Mishra A, Chhabria K, et al. (19 August 2020). "Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2". Frontiers in Cell and Developmental Biology. 8: 783. doi:10.3389/fcell.2020.00783. PMC 7466449. PMID 32974340.
  24. ↑ "Newborn triplets diagnosed with Covid-19 in stable condition, say Mexican health officials". CNN. Retrieved June 27, 2020.
  25. ↑ 25.0 25.1 Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. (July 2004). "Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome". American Journal of Obstetrics and Gynecology. 191 (1): 292–7. doi:10.1016/j.ajog.2003.11.019. PMC 7137614. PMID 15295381.
  26. ↑ Alfaraj SH, Al-Tawfiq JA, Memish ZA (June 2019). "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature". Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 52 (3): 501–503. doi:10.1016/j.jmii.2018.04.005. PMC 7128238. PMID 29907538.
  27. ↑ Mullins E, Evans D, Viner RM, O'Brien P, Morris E (May 2020). "Coronavirus in pregnancy and delivery: rapid review". Ultrasound in Obstetrics & Gynecology. 55 (5): 586–592. doi:10.1002/uog.22014. PMID 32180292. S2CID 212739349.
  28. ↑ Impact of the COVID-19 Pandemic on Family Planning and Ending Gender-based Violence, Female Genital Mutilation and Child Marriage (PDF). UNFPA. 2020.
  29. ↑ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention (in Turanci). 11 February 2020. Retrieved 19 March 2020.
  30. ↑ 30.00 30.01 30.02 30.03 30.04 30.05 30.06 30.07 30.08 30.09 "COVID-19 Technical Brief for Maternity Services". www.unfpa.org (in Turanci). Retrieved 2020-06-06.
  31. ↑ 31.0 31.1 Du L, Gu YB, Cui MQ, Li WX, Wang J, Zhu LP, Xu B (March 2020). "[Investigation on demands for antenatal care services among 2 002 pregnant women during the epidemic of COVID-19 in Shanghai]". Zhonghua Fu Chan Ke Za Zhi. 55 (3): 160–165. doi:10.3760/cma.j.cn112141-20200218-00112. PMID 32268713. S2CID 215611766.
  32. ↑ 32.0 32.1 32.2 Sutton D, Fuchs K, D'Alton M, Goffman D (May 2020). "Universal Screening for SARS-CoV-2 in Women Admitted for Delivery". The New England Journal of Medicine. 382 (22): 2163–2164. doi:10.1056/NEJMc2009316. PMC 7175422. PMID 32283004.
  33. ↑ 33.0 33.1 33.2 "COVID-19 Technical Brief for Maternity Services". www.unfpa.org (in Turanci). Retrieved 5 June 2020.
  34. ↑ Wastnedge EA, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, Critchley HO (January 2021). "Pregnancy and COVID-19". Physiological Reviews. 101 (1): 303–318. doi:10.1152/physrev.00024.2020. PMC 7686875. PMID 32969772.
  35. ↑ "COVID-19 Technical Brief for Maternity Services". www.unfpa.org (in Turanci). Retrieved 2020-06-22.
  36. ↑ "UN Secretary-General's policy brief: The impact of COVID-19 on women | Digital library: Publications". UN Women (in Turanci). Retrieved 5 June 2020.
Daga "https://ha.wikipedia.org/w/index.php?title=Cutar_Covid-19_A_Cikin_Ciki&oldid=498830"